About   Help   FAQ
Gene Ontology Classifications
Symbol
Name
ID
Il4
interleukin 4
MGI:96556

Go Annotations as Summary Text (Tabular View) (GO Graph)

GO curators for mouse genes have assigned the following annotations to the gene product of Il4. (This text reflects annotations as of Thursday, July 24, 2014.)
Summary from NCBI RefSeq


[Summary is not available for the mouse gene. This summary is for the human ortholog.] The protein encoded by this gene is a pleiotropic cytokine produced by activated T cells. This cytokine is a ligand for interleukin 4 receptor. The interleukin 4 receptor also binds to IL13, which may contribute to many overlapping functions of this cytokine and IL13. STAT6, a signal transducer and activator of transcription, has been shown to play a central role in mediating the immune regulatory signal of this cytokine. This gene, IL3, IL5, IL13, and CSF2 form a cytokine gene cluster on chromosome 5q, with this gene particularly close to IL13. This gene, IL13 and IL5 are found to be regulated coordinately by several long-range regulatory elements in an over 120 kilobase range on the chromosome. Two alternatively spliced transcript variants of this gene encoding distinct isoforms have been reported. [provided by RefSeq, Jul 2008]
Summary text based on GO annotations supported by experimental evidence in mouse
Summary text based on GO annotations supported by experimental evidence in other organisms
Summary text based on GO annotations supported by structural data
Summary text for additional MGI annotations
References
  1. Aldrich MB et al. (2003) Impaired germinal center maturation in adenosine deaminase deficiency. J Immunol, 171:5562-70. (PubMed:14607964)
  2. Ayllon V et al. (2002) The anti-apoptotic molecules Bcl-xL and Bcl-w target protein phosphatase 1alpha to Bad. Eur J Immunol, 32:1847-55. (PubMed:12115603)
  3. Casey LS et al. (1992) IL-4 induces IL-2 receptor p75 beta-chain gene expression and IL-2-dependent proliferation in mouse T lymphocytes. J Immunol, 148:3418-26. (PubMed:1588041)
  4. Castigli E et al. (2004) Impaired IgA class switching in APRIL-deficient mice. Proc Natl Acad Sci U S A, 101:3903-8. (PubMed:14988498)
  5. Chae WJ et al. (2006) The mutant leucine-zipper domain impairs both dimerization and suppressive function of Foxp3 in T cells. Proc Natl Acad Sci U S A, 103:9631-6. (PubMed:16769892)
  6. Chen Q et al. (2000) Development of Th1-type immune responses requires the type I cytokine receptor TCCR Nature, 407:916-20. (PubMed:11057672)
  7. Chu CC et al. (1998) Expressed genes in interleukin-4 treated B cells identified by cDNA representational difference analysis. Mol Immunol, 35:487-502. (PubMed:9798653)
  8. Cook KD et al. (2010) TCR-dependent translational control of GATA-3 enhances Th2 differentiation. J Immunol, 185:3209-16. (PubMed:20696860)
  9. Dardalhon V et al. (2008) IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells. Nat Immunol, 9:1347-55. (PubMed:18997793)
  10. de Yebenes VG et al. (2008) miR-181b negatively regulates activation-induced cytidine deaminase in B cells. J Exp Med, 205:2199-206. (PubMed:18762567)
  11. Dent AL et al. (1997) Control of inflammation, cytokine expression, and germinal center formation by BCL-6. Science, 276:589-92. (PubMed:9110977)
  12. Deshmukh HS et al. (2009) Critical role of NOD2 in regulating the immune response to Staphylococcus aureus. Infect Immun, 77:1376-82. (PubMed:19139201)
  13. Gerth AJ et al. (2003) T-bet regulates T-independent IgG2a class switching. Int Immunol, 15:937-44. (PubMed:12882831)
  14. Gessner A et al. (1994) Recombinant soluble interleukin-4 (IL-4) receptor acts as an antagonist of IL-4 in murine cutaneous Leishmaniasis. Infect Immun, 62:4112-7. (PubMed:7927664)
  15. Guo L et al. (2009) IL-1 family members and STAT activators induce cytokine production by Th2, Th17, and Th1 cells. Proc Natl Acad Sci U S A, 106:13463-8. (PubMed:19666510)
  16. Hervas-Stubbs S et al. (2007) Insect baculoviruses strongly potentiate adaptive immune responses by inducing type I IFN. J Immunol, 178:2361-9. (PubMed:17277142)
  17. Imada K et al. (1998) Stat5b is essential for natural killer cell-mediated proliferation and cytolytic activity. J Exp Med, 188:2067-74. (PubMed:9841920)
  18. Kim PJ et al. (2006) GATA-3 regulates the development and function of invariant NKT cells. J Immunol, 177:6650-9. (PubMed:17082577)
  19. King VL et al. (2002) Interleukin-4 deficiency promotes gallstone formation. J Lipid Res, 43:768-71. (PubMed:11971948)
  20. Kishimoto H et al. (1999) Several different cell surface molecules control negative selection of medullary thymocytes. J Exp Med, 190:65-73. (PubMed:10429671)
  21. Kitaura H et al. (2003) Interleukin-4 directly inhibits tumor necrosis factor-alpha-mediated osteoclast formation in mouse bone marrow macrophages. Immunol Lett, 88:193-8. (PubMed:12941478)
  22. Kobayashi K et al. (2002) RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems. Nature, 416:194-9. (PubMed:11894098)
  23. Kong YY et al. (1995) Differential requirements of CD45 for lymphocyte development and function. Eur J Immunol, 25:3431-6. (PubMed:8566034)
  24. Lacey DL et al. (1994) Interleukin 4 increases type 5 acid phosphatase mRNA expression in murine bone marrow macrophages. J Cell Biochem, 54:365-71. (PubMed:8200916)
  25. Li Z et al. (2011) ECM1 controls T(H)2 cell egress from lymph nodes through re-expression of S1P(1). Nat Immunol, 12:178-85. (PubMed:21217760)
  26. Lillard JW Jr et al. (1999) Lymphotactin acts as an innate mucosal adjuvant. J Immunol, 162:1959-65. (PubMed:9973465)
  27. Lin W et al. (2005) Allergic dysregulation and hyperimmunoglobulinemia E in Foxp3 mutant mice. J Allergy Clin Immunol, 116:1106-15. (PubMed:16275384)
  28. Moriggl R et al. (1999) Stat5 activation is uniquely associated with cytokine signaling in peripheral T cells. Immunity, 11:225-30. (PubMed:10485657)
  29. Motomura Y et al. (2011) The transcription factor E4BP4 regulates the production of IL-10 and IL-13 in CD4+ T cells. Nat Immunol, 12:450-9. (PubMed:21460847)
  30. Onodera A et al. (2010) STAT6-mediated displacement of polycomb by trithorax complex establishes long-term maintenance of GATA3 expression in T helper type 2 cells. J Exp Med, 207:2493-506. (PubMed:20956546)
  31. Pauleau AL et al. (2004) Enhancer-mediated control of macrophage-specific arginase I expression. J Immunol, 172:7565-73. (PubMed:15187136)
  32. Rumsaeng V et al. (1997) Lymphotactin gene expression in mast cells following Fc(epsilon) receptor I aggregation: modulation by TGF-beta, IL-4, dexamethasone, and cyclosporin A. J Immunol, 158:1353-60. (PubMed:9013979)
  33. Schenten D et al. (2006) M17, a gene specific for germinal center (GC) B cells and a prognostic marker for GC B-cell lymphomas, is dispensable for the GC reaction in mice. Blood, 107:4849-56. (PubMed:16493007)
  34. Sexl V et al. (2000) Stat5a/b contribute to interleukin 7-induced B-cell precursor expansion, but abl- and bcr/abl-induced transformation are independent of stat5 Blood, 96:2277-83. (PubMed:10979977)
  35. Stellato C et al. (2011) Coordinate regulation of GATA-3 and Th2 cytokine gene expression by the RNA-binding protein HuR. J Immunol, 187:441-9. (PubMed:21613615)
  36. Stuber E et al. (1995) Cross-linking of OX40 ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murine splenic B cells. Immunity, 2:507-21. (PubMed:7749983)
  37. Takeuchi O et al. (1999) Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity, 11:443-51. (PubMed:10549626)
  38. van Hamburg JP et al. (2008) Enforced expression of GATA3 allows differentiation of IL-17-producing cells, but constrains Th17-mediated pathology. Eur J Immunol, 38:2573-86. (PubMed:18792410)
  39. Walter W et al. (2000) MHC class II antigen presentation pathway in murine tumours: tumour evasion from immunosurveillance? Br J Cancer, 83:1192-201. (PubMed:11027433)
  40. Wang L et al. (2010) The sequential activity of Gata3 and Thpok is required for the differentiation of CD1d-restricted CD4+ NKT cells. Eur J Immunol, 40:2385-90. (PubMed:20706986)
  41. Witthuhn BA et al. (1994) Involvement of the Jak-3 Janus kinase in signalling by interleukins 2 and 4 in lymphoid and myeloid cells. Nature, 370:153-7. (PubMed:8022486)
  42. Xing Y et al. (2005) Protein phosphatase subunit G5PR is needed for inhibition of B cell receptor-induced apoptosis. J Exp Med, 202:707-19. (PubMed:16129705)
  43. Yagi R et al. (2010) The transcription factor GATA3 actively represses RUNX3 protein-regulated production of interferon-gamma. Immunity, 32:507-17. (PubMed:20399120)



Go Annotations in Tabular Form (Text View) (GO Graph)

 
 


Gene Ontology Evidence Code Abbreviations:

  EXP Inferred from experiment
  IC Inferred by curator
  IDA Inferred from direct assay
  IEA Inferred from electronic annotation
  IGI Inferred from genetic interaction
  IMP Inferred from mutant phenotype
  IPI Inferred from physical interaction
  ISS Inferred from sequence or structural similarity
  ISO Inferred from sequence orthology
  ISA Inferred from sequence alignment
  ISM Inferred from sequence model
  NAS Non-traceable author statement
  ND No biological data available
  RCA Reviewed computational analysis
  TAS Traceable author statement


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Tumor Biology (MTB), Gene Ontology (GO), MouseCyc
Citing These Resources
Funding Information
Warranty Disclaimer & Copyright Notice
Send questions and comments to User Support.
last database update
08/19/2014
MGI 5.19
The Jackson Laboratory